Chemistry:SR-15099

From HandWiki

SR-15099, also known as SR 2.0, is an atypical opioid and close analogue of SR-17018 and brorphine.[1][2][3] It is the analogue of SR-17018 in which the chlorine atom on the benzyl ring has been replaced with a bromine atom.[1][2] The drug is a non-competitive partial biased agonist of the μ-opioid receptor (MOR) similarly to SR-17018.[1][2] It has similar effects in animals as SR-17018, such as having robust analgesic effects but producing minimal respiratory depression or hyperlocomotion.[2][1][4] SR-15099 was first described in the scientific literature by Laura M. Bohn and colleagues by 2017.[2]

See also

References

  1. ↑ 1.0 1.1 1.2 1.3 "Hyperactivity in Mice Induced by Opioid Agonists with Partial Intrinsic Efficacy and Biased Agonism Administered Alone and in Combination with Morphine". Biomolecules 13 (6): 935. June 2023. doi:10.3390/biom13060935. PMID 37371516. 
  2. ↑ 2.0 2.1 2.2 2.3 2.4 "Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics". Cell 171 (5): 1165–1175.e13. November 2017. doi:10.1016/j.cell.2017.10.035. PMID 29149605. 
  3. ↑ "DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles". ACS Chemical Neuroscience 12 (7): 1072–1092. April 2021. doi:10.1021/acschemneuro.1c00037. PMID 33760580. 
  4. ↑ "Biased versus Partial Agonism in the Search for Safer Opioid Analgesics". Molecules (Basel, Switzerland) 25 (17): 3870. August 2020. doi:10.3390/molecules25173870. PMID 32854452.